174 related articles for article (PubMed ID: 29090354)
1. Molecular alterations in a new cell line (KU-Lu-MPPt3) established from a human lung adenocarcinoma with a micropapillary pattern.
Matsuo Y; Shiomi K; Sonoda D; Mikubo M; Naito M; Matsui Y; Yoshida T; Satoh Y
J Cancer Res Clin Oncol; 2018 Jan; 144(1):75-87. PubMed ID: 29090354
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonary adenocarcinoma with micropapillary pattern: a clinicopathologic and immunohistochemical study].
Zhang J; Liang ZY; Luo YF; Wan JW; Cao JL; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):651-6. PubMed ID: 20078967
[TBL] [Abstract][Full Text] [Related]
3. Immunostaining with EGFR mutation-specific antibodies: a reliable screening method for lung adenocarcinomas harboring EGFR mutation in biopsy and resection samples.
Fan X; Liu B; Xu H; Yu B; Shi S; Zhang J; Wang X; Wang J; Lu Z; Ma H; Zhou X
Hum Pathol; 2013 Aug; 44(8):1499-507. PubMed ID: 23465272
[TBL] [Abstract][Full Text] [Related]
4. Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma.
Ohe M; Yokose T; Sakuma Y; Miyagi Y; Okamoto N; Osanai S; Hasegawa C; Nakayama H; Kameda Y; Yamada K; Isobe T
Diagn Pathol; 2012 Jan; 7():3. PubMed ID: 22225786
[TBL] [Abstract][Full Text] [Related]
5. Primary lung adenocarcinoma with morule-like components: a unique histologic hallmark of aggressive behavior and EGFR mutation.
Tsuta K; Kawago M; Yoshida A; Sekine S; Asamura H; Furuta K; Kushima R
Lung Cancer; 2014 Jul; 85(1):12-8. PubMed ID: 24768118
[TBL] [Abstract][Full Text] [Related]
6. Stromal micropapillary pattern predominant lung adenocarcinoma--a report of two cases.
Ohe M; Yokose T; Sakuma Y; Osanai S; Hasegawa C; Washimi K; Nawa K; Woo T; Hamanaka R; Nakayama H; Kameda Y; Yamada K; Isobe T
Diagn Pathol; 2011 Sep; 6():92. PubMed ID: 21955603
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between EGFR Mutations and Pathological Classification and
Specimen of Lung Adenocarcinoma].
Kang L; Zheng J; Zhu X
Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):382-388. PubMed ID: 28641695
[TBL] [Abstract][Full Text] [Related]
8. Mucinous micropapillary pattern in lung adenocarcinomas: a unique histology with genetic correlates.
Kamata T; Yoshida A; Shiraishi K; Furuta K; Kosuge T; Watanabe S; Asamura H; Tsuta K
Histopathology; 2016 Feb; 68(3):356-66. PubMed ID: 26109197
[TBL] [Abstract][Full Text] [Related]
9. [To evaluate the clinicopathologic characteristics and outcome of tumor cells spreading through air spaces in patients with adenocarcinoma of lung].
Sun PL; Liu JN; Cao LQ; Yao M; Gao HW
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):303-308. PubMed ID: 28468034
[No Abstract] [Full Text] [Related]
10. Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis.
Zhang J; Liang Z; Gao J; Luo Y; Liu T
Histopathology; 2011 Dec; 59(6):1204-14. PubMed ID: 22175900
[TBL] [Abstract][Full Text] [Related]
11. A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.
Matsumura M; Okudela K; Kojima Y; Umeda S; Tateishi Y; Sekine A; Arai H; Woo T; Tajiri M; Ohashi K
PLoS One; 2016; 11(11):e0166795. PubMed ID: 27861549
[TBL] [Abstract][Full Text] [Related]
12. Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.
Stewart EL; Mascaux C; Pham NA; Sakashita S; Sykes J; Kim L; Yanagawa N; Allo G; Ishizawa K; Wang D; Zhu CQ; Li M; Ng C; Liu N; Pintilie M; Martin P; John T; Jurisica I; Leighl NB; Neel BG; Waddell TK; Shepherd FA; Liu G; Tsao MS
J Clin Oncol; 2015 Aug; 33(22):2472-80. PubMed ID: 26124487
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between histopathologic characteristics and epidermal growth factor receptor mutation in lung adenocarcinoma].
Wang K; Gong H; Li X; Yang Z; Cao P; Wand C; Jiang Y; Wang H; Wang Y; Zhang G
Zhonghua Bing Li Xue Za Zhi; 2015 Mar; 44(3):170-4. PubMed ID: 26268750
[TBL] [Abstract][Full Text] [Related]
14. Possible mechanism of metastasis in lung adenocarcinomas with a micropapillary pattern.
Miyoshi T; Shirakusa T; Ishikawa Y; Iwasaki A; Shiraishi T; Makimoto Y; Iwasaki H; Nabeshima K
Pathol Int; 2005 Jul; 55(7):419-24. PubMed ID: 15982217
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive investigation of molecular features and prognosis of lung adenocarcinoma with micropapillary component.
Zhang Y; Wang R; Cai D; Li Y; Pan Y; Hu H; Wang L; Li H; Ye T; Luo X; Zhang Y; Li B; Shen L; Sun Y; Chen H
J Thorac Oncol; 2014 Dec; 9(12):1772-8. PubMed ID: 25226429
[TBL] [Abstract][Full Text] [Related]
16. The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010.
Ito H; Date H; Shintani Y; Miyaoka E; Nakanishi R; Kadokura M; Endo S; Chida M; Yoshino I; Suzuki H;
BMC Cancer; 2022 Aug; 22(1):875. PubMed ID: 35948946
[TBL] [Abstract][Full Text] [Related]
17. Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma.
Tsai TH; Wu SG; Chang YL; Wu CT; Tsai MF; Wei PF; Yang CH; Yu CJ; Yang PC; Shih JY
J Thorac Oncol; 2012 Jun; 7(6):993-1000. PubMed ID: 22525557
[TBL] [Abstract][Full Text] [Related]
18. Lymph node involvement influenced by lung adenocarcinoma subtypes in tumor size ≤3 cm disease: A study of 2268 cases.
Yu Y; Jian H; Shen L; Zhu L; Lu S
Eur J Surg Oncol; 2016 Nov; 42(11):1714-1719. PubMed ID: 27017272
[TBL] [Abstract][Full Text] [Related]
19. High-grade lung adenocarcinomas with micropapillary and/or solid patterns: a review.
Morales-Oyarvide V; Mino-Kenudson M
Curr Opin Pulm Med; 2014 Jul; 20(4):317-23. PubMed ID: 24852329
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of regulator of G protein signaling 11 promotes cell migration and associates with advanced stages and aggressiveness of lung adenocarcinoma.
Yang SH; Li CF; Chu PY; Ko HH; Chen LT; Chen WW; Han CH; Lung JH; Shih NY
Oncotarget; 2016 May; 7(21):31122-36. PubMed ID: 27105500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]